Virtual Conference
Pharma Conference 2022

Luisetto M

IMA academy Marijnskaya , Italy

Title: Graphene and Derivates : Physico- chemical and toxicology properties in the m- Rna vaccine manifacturing strategy Needed specific proof of absence for the regulatory aspects


Observing the fact that every year various registerd and authorized  drugs are recalled by the public regulatory agency  ( in example last Ranitidin  cases due by the possibility of impurity presence of a cancerogenic sustantia ) it is interesting to observe the innovative production strategy of some m RNA vaccine . Also for  the bio- technological  drugs product   the regulatory agency ask quality stantard for impurity  for the obiously safety implications. The biotechnological drugs , as the classic chemical drugs , due by the complex  manifacturing process use raw material and industrial procedure that require Great quality monitoring according the GMP normative rules. So it is no to strange to  discuss of impurities in this new kind of products And  also for the covid-19 vaccine .


To be added